Literature DB >> 667941

Characterization of beta-globin mRNA in the beta0 thalassemias.

J M Old, N J Proudfoot, W G Wood, J I Longley, J B Clegg, D J Weatherall.   

Abstract

A number of cases of beta0 thalassemia have been examined for the presence or absence of beta-globin mRNA. Total RNA extracted from peripheral blood was hybridized to purified complementary DNA specific for beta-globin mRNA, and to beta-cDNA probes specific for the 5' and 3' noncoding regions of beta-globin mRNA. Three clear-cut categories of beta0 thalassemia were identified. The first type had no detectable beta-globin mRNA. A second typed had beta-globin mRNA sequences which hybridized incompletely to the cDNA probes and probably represented mRNAs with grossly altered structures. A third type appeared to have essentially intact, though untranslatable, beta-globin mRNA. Depurination products from 5' and 3' beta-cDNAs synthesized from this latter mRNA were identical to those from normal beta-globin mRNA, but the relative yields were different, suggesting a possible defect near the initiation codon.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 667941     DOI: 10.1016/0092-8674(78)90115-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  11 in total

1.  2003 William Allan Award address. The Thalassemias: the role of molecular genetics in an evolving global health problem.

Authors:  David Weatherall
Journal:  Am J Hum Genet       Date:  2004-03       Impact factor: 11.025

2.  The structure of the human beta-globin gene in beta-thalassaemia.

Authors:  R A Flavell; R Bernards; J M Kooter; E de Boer; P F Little; G Annison; R Williamson
Journal:  Nucleic Acids Res       Date:  1979-06-25       Impact factor: 16.971

3.  beta-Thalassemia present in cis to a new beta-chain structural variant, Hb Vicksburg [beta 75 (E19)Leu leads to 0].

Authors:  J G Adams; M H Steinberg; M V Newman; W T Morrison; E J Benz; R Iyer
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

4.  Genetic and molecular diversity in nondeletion Hb H disease.

Authors:  D R Higgs; L Pressley; B Aldridge; J B Clegg; D J Weatherall; A Cao; M G Hadjiminas; C Kattamis; A Metaxatou-Mavromati; E A Rachmilewitz; T Sophocleous
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

Review 5.  The thalassemias: molecular mechanisms of human genetic disease.

Authors:  R A Spritz; B G Forget
Journal:  Am J Hum Genet       Date:  1983-05       Impact factor: 11.025

6.  Partial deletion of beta-globin gene DNA in certain patients with beta 0-thalassemia.

Authors:  S H Orkin; J M Old; D J Weatherall; D G Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

Review 7.  The molecular basis of disorders of human hemoglobin synthesis.

Authors:  F Ramirez; J G Mears; A Bank
Journal:  Mol Cell Biochem       Date:  1980-08-16       Impact factor: 3.396

8.  Heterogeneity in beta 0 thalassemia from Algeria: genetic, clinical and molecular studies.

Authors:  M Belhani; F Morlé; P Colonna; J Godet
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

9.  beta 0 thalassemia, a nonsense mutation in man.

Authors:  J C Chang; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

10.  A nucleotide change at a splice junction in the human beta-globin gene is associated with beta 0-thalassemia.

Authors:  M Baird; C Driscoll; H Schreiner; G V Sciarratta; G Sansone; G Niazi; F Ramirez; A Bank
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.